The Hi-C data from the LNCaP prostate cancer cells corroborates the C3D predictions as demonstrated by the elevated contact frequency between the region harboring the FOXA1 promoter and where the six CREs are located, compared with other loci in the same TAD (Fig. 3a). Here, FOXA1 is linked to prostate carcinoma.